Unity Biotechnology Statistics

Total Valuation

UBX has a market cap or net worth of $25.35 million. The enterprise value is $5.68 million.

Market Cap	25.35M
Enterprise Value	5.68M

Important Dates

The last earnings date was Monday, April 15, 2024, before market open.

Earnings Date	Apr 15, 2024
Ex-Dividend Date	n/a

Share Statistics

UBX has 16.79 million shares outstanding. The number of shares has increased by 55.60% in one year.

Shares Outstanding	16.79M
Shares Change (YoY)	+55.60%
Shares Change (QoQ)	+7.92%
Owned by Insiders (%)	1.25%
Owned by Institutions (%)	28.33%
Float	12.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.89
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.95, with a Debt / Equity ratio of 0.83.

Current Ratio	5.95
Quick Ratio	n/a
Debt / Equity	0.83
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.26

Financial Efficiency

Return on equity (ROE) is -92.40% and return on invested capital (ROIC) is -86.00%.

Return on Equity (ROE)	-92.40%
Return on Assets (ROA)	-45.50%
Return on Capital (ROIC)	-86.00%
Revenue Per Employee	n/a
Profits Per Employee	-$1.81M
Employee Count	22
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.62% in the last 52 weeks. The beta is 0.87, so UBX's price volatility has been lower than the market average.

Beta (1Y)	0.87
52-Week Price Change	-38.62%
50-Day Moving Average	1.66
200-Day Moving Average	2.06
Relative Strength Index (RSI)	39.34
Average Volume (30 Days)	90,872

Short Selling Information

The latest short interest is 307,177, so 1.83% of the outstanding shares have been sold short.

Short Interest	307,177
Short Previous Month	291,629
Short % of Shares Out	1.83%
Short % of Float	2.43%
Short Ratio (days to cover)	2.18

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-44.67M
Pretax Income	-39.86M
Net Income	-39.86M
EBITDA	-36.23M
EBIT	-37.41M
Earnings Per Share (EPS)	-$2.70

Full Income Statement

Balance Sheet

The company has $43.20 million in cash and $23.54 million in debt, giving a net cash position of $19.66 million or $1.17 per share.

Cash & Cash Equivalents	43.20M
Total Debt	23.54M
Net Cash	19.66M
Net Cash Per Share	$1.17
Equity / Book Value	28.40M
Book Value Per Share	1.69
Working Capital	38.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$37.09 million and capital expenditures $104,000, giving a free cash flow of -$36.98 million.

Operating Cash Flow	-37.09M
Capital Expenditures	104,000
Free Cash Flow	-36.98M
FCF Per Share	-$2.50

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

UBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-55.60%
Shareholder Yield	-55.60%
Earnings Yield	-157.27%
FCF Yield	-145.92%

Analyst Forecast

The average price target for UBX is $8.50, which is 462.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	462.91%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	164.64%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 20, 2022. It was a reverse split with a ratio of 1:10.

Last Split Date	Oct 20, 2022
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	3